We work to provide home health care you can trust.

For Investors

Amedisys, Inc. (NASDAQ: AMED) is a leading health care company focused on bringing home the continuum of care. Amedisys delivers personalized health care services to patients and their families, in the comfort of patients’ homes, with approximately 10 million patient care and education encounters per year. Amedisys has two divisions, home health care and hospice. The Company’s state-of-the-art advanced chronic care management programs and leading-edge technology enables it to deliver quality care based u... More >>

Recent News

More >>
DateTitle 
Dec 5, 2016Amedisys Foundation and Dream Foundation Partner to Serve Terminally-Ill Patients and Their Families
BATON ROUGE, La., Dec. 05, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), one of the nation’s leading home health care and hospice companies, announced today a partnership between the Amedisys Foundation and Dream Foundation, the only national dream-granting organization for terminally-ill adults.  Through this newly formed partnership, Amedisys hospice care centers across the nation will have an opportunity to turn a patient’s Dream into reality. ... 
Printer Friendly Version
Nov 10, 20162016 HomeCare Elite Recognizes Top Amedisys Care Teams Nationwide
147 Amedisys Home Health Care Centers recognized BATON ROUGE, La., Nov. 10, 2016 (GLOBE NEWSWIRE) -- Amedisys, a leading healthcare at home company (NASDAQ:AMED), today announced that 45% of its care centers across the country have been named to the 2016 HomeCare Elite™, a recognition of the top-performing home health agencies in the United States. This includes 14 care centers on the Top 500 list and an additional four on the Top 100 list. For more than ten years, HomeCare Elite has annually... 
Printer Friendly Version
Nov 4, 2016Amedisys Brings In Christopher Gerard As New Chief Operating Officer
BATON ROUGE, La., Nov. 04, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), a leading home health, hospice and personal care company, announced today that industry leader Christopher Gerard will join the Company as Chief Operating Officer (COO) on January 3, 2017. Daniel McCoy will remain in this role until January 3, 2017. Gerard brings more than 20 years of home health and hospice experience to the Company. In his new role, Gerard will be responsible for the Amedisys’ home health, h... 
Printer Friendly Version
Nov 3, 2016Amedisys Reports Third Quarter Financial Results
Amedisys to Host Conference Call November 4, 2016 at 11:00 a.m. ET BATON ROUGE, La., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), a leading home health and hospice company, today reported its financial results for the three and nine-month periods ended September 30, 2016. Three-Month Periods Ended September 30, 2016 and 2015 Net service revenue increased $35.2 million to $361.6 million compared to $326.4 million in 2015. Net income attributable to Amedisys, In... 
Printer Friendly Version
DateTitle 
11/03/16Amedisys Reports Third Quarter Financial Results
Amedisys to Host Conference Call November 4, 2016 at 11:00 a.m. ET BATON ROUGE, La., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), a leading home health and hospice company, today reported its financial results for the three and nine-month periods ended September 30, 2016. Three-Month Periods Ended September 30, 2016 and 2015 Net service revenue increased $35.2 million to $361.6 million compared to $326.4 million in 2015. Net income attributable to Amedisys, In... 
Printer Friendly Version
08/02/16Amedisys Reports Second Quarter Financial Results
ANNOUNCES EXECUTIVE RETIREMENT TO HOST CONFERENCE CALL AUGUST 3, 2016 AT 11:00 A.M. ET BATON ROUGE, La., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), a leading home health and hospice company, today reported its financial results for the three and six-month periods ended June 30, 2016. Three-Month Periods Ended June 30, 2016 and 2015  Net service revenue increased $46.6 million to $360.7 million compared to $314.1 million in 2015. Net income attributable to Am... 
Printer Friendly Version
07/26/16Amedisys Announces Second Quarter Earnings Release and Conference Call Date
BATON ROUGE, La., July 26, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), one of America’s leading home health and hospice care companies, announced today that it will report results for the second quarter ended June 30, 2016 after the market closes on August 2, 2016.  The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on August 3, 2016. To participate on the conference call, please call a few minutes before 11:00 a.m. ET to either (877) 524-... 
Printer Friendly Version
05/03/16Amedisys Reports First Quarter Financial Results
Amedisys to Host Conference Call May 4, 2016 at 11:00 A.M. ET BATON ROUGE, La., May 03, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), a leading home health and hospice company, today reported its financial results for the three-month period ended March 31, 2016. Three-Month Periods Ended March 31, 2016 and 2015 Net service revenue increased $47.2 million or 15.6% to $348.8 million compared to $301.6 million in 2015. Net income attributable to Amedisys, Inc. increased $41.... 
Printer Friendly Version
There are currently no events scheduled.
Filing DateFormDescription
11/14/164Statement of changes in beneficial ownership of securities
IMPORTANT NOTICE TO USERS (summary only, click here for full text of notice): Certain financial and other information on the Investor Relations website is reproduced or derived from more comprehensive information contained in our quarterly earnings releases and periodic reports and other filings with the Securities and Exchange Commission. The information contained on the Investor Relations website is not intended as a substitute for, and should be read in the context of, the more comprehensive information contained in these other documents. In the event of any conflict, the information contained in our quarterly earnings releases and our periodic reports and filings with the SEC shall take precedence.